Premium
P4–312: Preclinical characterization of RO4602522, a novel, selective and orally active monoamine oxidase type B inhibitor for the treatment of Alzheimer's disease
Author(s) -
Borroni Edilio,
Wyler Rene,
Messer Juergen,
Nave Stephane,
Cesura Andrea
Publication year - 2013
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2013.05.1757
Subject(s) - monoamine oxidase b , monoamine oxidase , dopaminergic , monoamine oxidase a , chemistry , monoamine neurotransmitter , pharmacology , dopamine , oxidative stress , biochemistry , amyloid precursor protein , enzyme , alzheimer's disease , receptor , endocrinology , serotonin , medicine , biology , disease